Want to join the conversation?
$AEO said based on an expected low single digit rise in comparable sales, the company expects 3Q16 EPS to be approx. $0.40-0.41. This guidance excludes potential asset impairment and restructuring charges and compares to EPS of $0.35 last year. For FY16, $AEO expects CapEx to be approx. $160MM, on the low end of the prior guidance of $160-170MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.